Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 29;46(1):56.
doi: 10.1186/s13052-020-0820-x.

Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far

Domenico Umberto De Rose  1 , Fiammetta Piersigilli  1   2 , Maria Paola Ronchetti  1 , Alessandra Santisi  1 , Iliana Bersani  1 , Andrea Dotta  1 , Olivier Danhaive  2 , Cinzia Auriti  3 ; Study Group of Neonatal Infectious Diseases of The Italian Society of Neonatology (SIN)
Affiliations
Review

Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far

Domenico Umberto De Rose et al. Ital J Pediatr. .

Abstract

Recently, an outbreak of viral pneumonitis in Wuhan, Hubei, China successively spread as a global pandemia, led to the identification of a novel betacoronavirus species, the 2019 novel coronavirus, successively designated 2019-nCoV then SARS-CoV-2). The SARS-CoV-2 causes a clinical syndrome designated coronavirus disease 2019 (COVID19) with a spectrum of manifestations ranging from mild upper respiratory tract infection to severe pneumonitis, acute respiratory distress syndrome (ARDS) and death. Few cases have been observed in children and adolescents who seem to have a more favorable clinical course than other age groups, and even fewer in newborn babies. This review provides an overview of the knowledge on SARS-CoV-2 epidemiology, transmission, the associated clinical presentation and outcomes in newborns and infants up to 6 months of life.

Keywords: COVID-19; Coronavirus; Infants; Newborns; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Comment in

References

    1. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490–502. doi: 10.1016/j.tim.2016.03.003. - DOI - PMC - PubMed
    1. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–192. doi: 10.1038/s41579-018-0118-9. - DOI - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020:1–7. 10.1056/NEJMoa2001017. - PMC - PubMed
    1. World Health Organization. Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Accessed 15 March 2020. n.d.
    1. Gorbalenya AE, Baker SC, Baric RS, De GRJ, Gulyaeva AA, Haagmans BL, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group. BioRxiv. 2020;11:1–15. doi: 10.1101/2020.02.07.937862. - DOI

LinkOut - more resources